Revvity Balance Sheet Health
Financial Health criteria checks 4/6
Revvity has a total shareholder equity of $7.9B and total debt of $3.9B, which brings its debt-to-equity ratio to 49.5%. Its total assets and total liabilities are $13.6B and $5.7B respectively. Revvity's EBIT is $381.5M making its interest coverage ratio 14.3. It has cash and short-term investments of $1.6B.
Key information
49.5%
Debt to equity ratio
US$3.90b
Debt
| Interest coverage ratio | 14.3x |
| Cash | US$1.60b |
| Equity | US$7.87b |
| Total liabilities | US$5.69b |
| Total assets | US$13.56b |
Recent financial health updates
We Think Revvity (NYSE:RVTY) Can Stay On Top Of Its Debt
Feb 28
Is Revvity (NYSE:RVTY) Using Too Much Debt?
Oct 07Revvity (NYSE:RVTY) Seems To Use Debt Quite Sensibly
Jul 03We Think PerkinElmer (NYSE:PKI) Can Stay On Top Of Its Debt
Mar 28PerkinElmer (NYSE:PKI) Has A Pretty Healthy Balance Sheet
Dec 27Recent updates
Why We're Not Concerned About Revvity, Inc.'s (NYSE:RVTY) Share Price
Apr 03Revvity: Enter Now As Reorganization Takes Shape
Mar 21We Think Revvity (NYSE:RVTY) Can Stay On Top Of Its Debt
Feb 28Investors Can Find Comfort In Revvity's (NYSE:RVTY) Earnings Quality
Feb 13Should You Think About Buying Revvity, Inc. (NYSE:RVTY) Now?
Jan 19An Intrinsic Calculation For Revvity, Inc. (NYSE:RVTY) Suggests It's 49% Undervalued
Jan 04Revvity: More Than A Name Change Is Needed For PerkinElmer
Dec 29Why We're Not Concerned About Revvity, Inc.'s (NYSE:RVTY) Share Price
Dec 20Is Revvity (NYSE:RVTY) Using Too Much Debt?
Oct 07Revvity: Recent Investments, Acquisitions, Not Pulling Economic Weight (Rating Downgrade)
Oct 04At US$108, Is Revvity, Inc. (NYSE:RVTY) Worth Looking At Closely?
Sep 22An Intrinsic Calculation For Revvity, Inc. (NYSE:RVTY) Suggests It's 40% Undervalued
Aug 17Revvity: New Name - But New Investment Outlook? Reiterate Buy
Jul 18Revvity (NYSE:RVTY) Seems To Use Debt Quite Sensibly
Jul 03What Does Revvity, Inc.'s (NYSE:RVTY) Share Price Indicate?
Jun 17Calculating The Fair Value Of Revvity, Inc. (NYSE:PKI)
May 16We Think PerkinElmer (NYSE:PKI) Can Stay On Top Of Its Debt
Mar 28When Should You Buy PerkinElmer, Inc. (NYSE:PKI)?
Mar 13PerkinElmer Q4 2022 Earnings Preview
Feb 13A Look At The Intrinsic Value Of PerkinElmer, Inc. (NYSE:PKI)
Feb 10PerkinElmer: Capital Budgeting A Key Factor To The Investment Debate
Jan 31Danaher earnings weigh on other life sciences tools, services companies
Jan 24PerkinElmer says Q4 results will meet or exceed prior guidance
Jan 09PerkinElmer (NYSE:PKI) Has A Pretty Healthy Balance Sheet
Dec 27Is It Time To Consider Buying PerkinElmer, Inc. (NYSE:PKI)?
Dec 12PerkinElmer receives FDA approval for EONIS assay for spinal muscular atrophy in newborns
Nov 14PerkinElmer reports mixed Q3 earnings, initiates Q4 and updates FY22 pro forma guidance
Nov 08PerkinElmer, Inc.'s (NYSE:PKI) Intrinsic Value Is Potentially 48% Above Its Share Price
Oct 28PerkinElmer declares $0.07 dividend
Oct 27Financial Position Analysis
Short Term Liabilities: RVTY's short term assets ($3.0B) exceed its short term liabilities ($1.5B).
Long Term Liabilities: RVTY's short term assets ($3.0B) do not cover its long term liabilities ($4.2B).
Debt to Equity History and Analysis
Debt Level: RVTY's net debt to equity ratio (29.2%) is considered satisfactory.
Reducing Debt: RVTY's debt to equity ratio has reduced from 71.8% to 49.5% over the past 5 years.
Debt Coverage: RVTY's debt is not well covered by operating cash flow (2.3%).
Interest Coverage: RVTY's interest payments on its debt are well covered by EBIT (14.3x coverage).